BioAtla, Inc.
BCAB
$0.88
$0.055.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -49.05% | 11.20% | 34.00% | 44.72% | 68.23% |
| Total Depreciation and Amortization | -75.44% | -49.78% | -23.75% | -38.04% | -15.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.47% | -32.93% | -110.22% | -58.98% | -37.62% |
| Change in Net Operating Assets | -19.85% | 431.21% | 91.10% | 46.75% | 38.26% |
| Cash from Operations | -92.54% | 26.43% | 47.16% | 43.91% | 81.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -80.74% | -- | 6,150.34% | -100.00% |
| Repurchase of Common Stock | 57.14% | 73.68% | -123.08% | 100.00% | 74.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 57.14% | -116.00% | -2,938.46% | 7,726.05% | 65.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -92.13% | 25.37% | 45.91% | 74.94% | 81.23% |